Negative Pressure Dressing Therapy in Soft Tissue Sarcoma Surgery
NCT ID: NCT02901405
Last Updated: 2021-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
17 participants
INTERVENTIONAL
2016-10-18
2020-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be randomised into either NPWT or standard absorbent dressings with primary outcome measure of surgical site infection according to the Health Protection Agency guidance. Secondary outcomes are; time to wound dryness, delayed discharge from hospital, adverse events, cost estimation
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Negative Pressure Wound Therapy
120 hours of negative pressure wound therapy (ActiVAC, KCI) applied to a primarily closed ('acute') wound.
Negative Pressure Wound Therapy (ActivVAC, KCI)
Standard dressings
Absorbant dressings applied in a standard fashion, i.e. only changed as necessary
Standard dressings
Current absorbent dressing is 'tegaderm with absorbent pad' (3M)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Negative Pressure Wound Therapy (ActivVAC, KCI)
Standard dressings
Current absorbent dressing is 'tegaderm with absorbent pad' (3M)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Children
* Post radiation sarcomas or sarcoma in presence of active infection
* Multiple metastatic disease
* Presence of Endoprosthesis
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Greater Glasgow and Clyde
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanjay Gupta, MBBS
Role: PRINCIPAL_INVESTIGATOR
NHS Greater Glasgow and Clyde
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glasgow Royal Infirmary
Glasgow, Scotland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GN15OR558
Identifier Type: -
Identifier Source: org_study_id